Literature DB >> 3491836

Constitutive expression of the granulocyte-macrophage colony-stimulating factor gene in acute myeloblastic leukemia.

D C Young, K Wagner, J D Griffin.   

Abstract

Expression of the granulocyte-macrophage colony-stimulating factor (GM-CSF) gene was studied by Northern blot analysis in normal human hematopoietic cells and a series of leukemias. GM-CSF messenger (m)RNA was detected in activated T cells, but not in normal bone marrow cells, monocytes, or nonactivated T cells. In contrast, leukemic cells from 11 of 22 cases of acute myeloblastic leukemia expressed GM-CSF transcripts. Biologically active CSF was detected in supernatant conditioned by 6 of these 11 leukemias. Expression of the GM-CSF gene was not detected in "common" (pre-B cell) acute lymphoblastic leukemia (11 cases tested) or chronic myeloid leukemia (4 cases tested). These results show that the GM-CSF gene is constitutively expressed in a subset of patients with AML, and further suggest that expression of this gene could contribute to the abnormal growth properties characteristic of AML.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3491836      PMCID: PMC423997          DOI: 10.1172/JCI112769

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Human cell lines that elaborate colon-stimulating activity for the marrow cells of man and other species.

Authors:  J F Di Persio; J K Brennan; M A Lichtman; B L Speiser
Journal:  Blood       Date:  1978-03       Impact factor: 22.113

2.  Colony assay for proliferative blast cells circulating in myeloblastic leukaemia.

Authors:  R N Buick; J E Till; E A McCulloch
Journal:  Lancet       Date:  1977-04-16       Impact factor: 79.321

3.  Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue.

Authors:  D J Capon; E Y Chen; A D Levinson; P H Seeburg; D V Goeddel
Journal:  Nature       Date:  1983-03-03       Impact factor: 49.962

4.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  Autostimulation of growth by human myelogenous leukemia cells (HL-60).

Authors:  J K Brennan; C N Abboud; J F DiPersio; G H Barlow; M A Lichtman
Journal:  Blood       Date:  1981-10       Impact factor: 22.113

Review 6.  Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies.

Authors:  L M Nadler; J Ritz; J D Griffin; R F Todd; E L Reinherz; S F Schlossman
Journal:  Prog Hematol       Date:  1981

7.  Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia.

Authors:  R N Buick; M D Minden; E A McCulloch
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

8.  Proliferative state of blast cell progenitors in acute myeloblastic leukemia (AML).

Authors:  M D Minden; J E Till; E A McCulloch
Journal:  Blood       Date:  1978-09       Impact factor: 22.113

9.  In vitro differentiation of leukemic progenitor cells in various types of acute nonlymphocytic leukemia.

Authors:  K Ozawa; Y Miura; T Suda; K Motoyoshi; F Takaku
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

10.  Expression of myeloid differentiation antigens on normal and malignant myeloid cells.

Authors:  J D Griffin; J Ritz; L M Nadler; S F Schlossman
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

View more
  33 in total

1.  Monosomy 7 provides a proliferative advantage for leukemic cells under incubation with GM-CSF in vitro.

Authors:  D Haase; C Fonatsch
Journal:  Blut       Date:  1990-11

Review 2.  Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.

Authors:  F Herrmann; R Mertelsmann
Journal:  Blut       Date:  1989-03

Review 3.  The role of colony-stimulating factors in acute leukemia.

Authors:  F Herrmann; E Vellenga
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

4.  Hematopoietic growth factors.

Authors:  C A Sieff
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

Review 5.  Colony-stimulating factors in the pathogenesis and treatment of disease.

Authors:  D J Williamson; C G Begley
Journal:  Postgrad Med J       Date:  1987-12       Impact factor: 2.401

6.  Deoxyribonucleic acid triplex formation inhibits granulocyte macrophage colony-stimulating factor gene expression and suppresses growth in juvenile myelomonocytic leukemic cells.

Authors:  M Kochetkova; P O Iversen; A F Lopez; M F Shannon
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

7.  Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control.

Authors:  W Oster; N A Cicco; H Klein; T Hirano; T Kishimoto; A Lindemann; R H Mertelsmann; F Herrmann
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

8.  Recombinant tumor necrosis factor alpha and interleukin 1 alpha increase expression of c-abl protooncogene mRNA in cultured human marrow stromal cells.

Authors:  D F Andrews; J J Nemunaitis; J W Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

9.  Granulocyte-macrophage colony-stimulating factor induces cytokine secretion by human polymorphonuclear leukocytes.

Authors:  A Lindemann; D Riedel; W Oster; H W Ziegler-Heitbrock; R Mertelsmann; F Herrmann
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

10.  Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro.

Authors:  M T Mitjavila; J P Le Couedic; N Casadevall; S Navarro; J L Villeval; A Dubart; W Vainchenker
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.